北京天坛医院铁制剂利用5年动态研究  

Utilization of Iron Agents in Beyjing Tiantan Hospital

作　　者：朱勇[1] 孟雅君[1] 杨久匣 

机构地区：[1]北京天坛医院药剂科,100050 [2]北京公安医院药剂科

出　　处：《中国药师》2000年第1期22-23,共2页China Pharmacist

摘　　要：统计北京天坛医院1994年1月至1998年6月铁制剂的购药数量、金额。采用WHO推荐的“限定日剂量(DDD)”作为药物研究的剂量单位,计算用药频度(DDDs)及日均费用。结果显示,我院铁制剂利用以口服铁剂为主,其中部分为进口铁剂;口服铁剂中,多糖铁复合物胶囊、枸橼酸铁铵片应用较多,琥珀酸亚铁片作为预防和治疗缺铁性贫血的首选药物;注射铁剂中,右旋糖酐铁注射液应用较多。提示我院药品淘汰和引进情况基本合理,能够基本满足临床的需要。Aim: To study the utilization of iron agents consumed in Beijing Tiantan Hospital during the period from 1994 to 1998. Method: The amount and expenditure of iron agents consumed in the hospital were investigated from 1994 to 1998. The data were analyzed in using drug used frequency and expenditure. The daily drug expenditure for each category was calculated. Results: The main iron agents were taken orally in the hospital and some of them were imported. In oral iron agents, polysaccha-ride iron complex and ferric ammonium citrate were used more frequent, and ferrous succinate was the first choice of treatment of iron deficiency anemia. The iron dextran was used only in the iron agents for injection. Conclusion: The iron agentsen the hospital could basically meet the clinical need.

关 键 词：贫血 缺铁性贫血 药物疗法 铁制剂 

分 类 号：R556.305[医药卫生—血液循环系统疾病] R977.9[医药卫生—内科学]